Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ZYDUS LIFESCIENCES ALEMBIC PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 38.8 17.9 216.9% View Chart
P/BV x 2.3 2.1 107.7% View Chart
Dividend Yield % 1.6 0.7 234.2%  

Financials

 ALEMBIC PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-22
ZYDUS LIFESCIENCES
Mar-22
ALEMBIC PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,090674 161.8%   
Low Rs672331 203.0%   
Sales per share (Unadj.) Rs269.9149.1 181.0%  
Earnings per share (Unadj.) Rs26.222.7 115.4%  
Cash flow per share (Unadj.) Rs40.829.7 137.5%  
Dividends per share (Unadj.) Rs10.002.50 400.0%  
Avg Dividend yield %1.10.5 228.1%  
Book value per share (Unadj.) Rs266.5166.1 160.5%  
Shares outstanding (eoy) m196.561,023.74 19.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.33.4 96.9%   
Avg P/E ratio x33.622.1 151.9%  
P/CF ratio (eoy) x21.616.9 127.5%  
Price / Book Value ratio x3.33.0 109.3%  
Dividend payout %38.111.0 346.5%   
Avg Mkt Cap Rs m173,172514,277 33.7%   
No. of employees `000NANA-   
Total wages/salary Rs m11,33021,777 52.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,058152,652 34.8%  
Other income Rs m5052,354 21.4%   
Total revenues Rs m53,563155,006 34.6%   
Gross profit Rs m8,74134,427 25.4%  
Depreciation Rs m2,8687,130 40.2%   
Interest Rs m1771,270 14.0%   
Profit before tax Rs m6,20128,381 21.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0455,117 20.4%   
Profit after tax Rs m5,15723,264 22.2%  
Gross profit margin %16.522.6 73.1%  
Effective tax rate %16.818.0 93.4%   
Net profit margin %9.715.2 63.8%  
BALANCE SHEET DATA
Current assets Rs m29,748122,614 24.3%   
Current liabilities Rs m18,30678,394 23.4%   
Net working cap to sales %21.629.0 74.4%  
Current ratio x1.61.6 103.9%  
Inventory Days Days1193 11.4%  
Debtors Days Days680 7.0%  
Net fixed assets Rs m42,554144,382 29.5%   
Share capital Rs m3931,024 38.4%   
"Free" reserves Rs m51,982168,972 30.8%   
Net worth Rs m52,375169,996 30.8%   
Long term debt Rs m03,621 0.0%   
Total assets Rs m72,302266,996 27.1%  
Interest coverage x36.023.3 154.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.6 128.4%   
Return on assets %7.49.2 80.3%  
Return on equity %9.813.7 71.9%  
Return on capital %12.217.1 71.3%  
Exports to sales %43.80-   
Imports to sales %12.714.3 88.5%   
Exports (fob) Rs m23,251NA-   
Imports (cif) Rs m6,72821,869 30.8%   
Fx inflow Rs m23,25163,065 36.9%   
Fx outflow Rs m6,72821,869 30.8%   
Net fx Rs m16,52341,196 40.1%   
CASH FLOW
From Operations Rs m5,52421,041 26.3%  
From Investments Rs m-3,72011,544 -32.2%  
From Financial Activity Rs m-2,174-8,683 25.0%  
Net Cashflow Rs m-37023,729 -1.6%  

Share Holding

Indian Promoters % 69.1 74.9 92.3%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 18.1 14.9 121.6%  
FIIs % 5.9 2.9 207.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 25.1 121.0%  
Shareholders   101,457 455,624 22.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    LUPIN    


More on ALEMBIC PHARMA vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Cadila Healthcare Share Price Performance

Period ALEMBIC PHARMA Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.28% -1.78% -0.46%
1-Month -6.39% -7.14% 0.65%
1-Year -25.73% -37.11% -13.70%
3-Year CAGR 4.20% 13.13% 20.93%
5-Year CAGR 4.71% -5.84% 10.98%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Cadila Healthcare the stake stands at 74.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 38.1%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

5 Reasons Why Sensex Plunged 1,021 Points Today(Closing)

After opening the day on a negative note, Indian share markets extended losses as the session progressed and ended deep in the red.